Spontaneous pneumothorax-When do we need to intervene?


Journal

The clinical respiratory journal
ISSN: 1752-699X
Titre abrégé: Clin Respir J
Pays: England
ID NLM: 101315570

Informations de publication

Date de publication:
Sep 2021
Historique:
revised: 02 05 2021
received: 23 11 2020
accepted: 04 05 2021
pubmed: 18 5 2021
medline: 11 9 2021
entrez: 17 5 2021
Statut: ppublish

Résumé

Pneumothorax can be classified as traumatic, iatrogenic or spontaneous (SP), which can be subdivided into primary spontaneous pneumothorax (PSP), a condition without preexisting lung disease, or secondary spontaneous pneumothorax (SSP) a complication of a preexisting lung disease. Recurrence rate of PSP is 30% whereas for SSP rate is unknown. This article explores the experience of a tertiary center over 20 years. A retrospective case review of patients hospitalized with pneumothorax to investigate the natural history and treatment of SP in a young population in a single tertiary center was conducted. A search of the digital archive (going back to 01/01/1995) of Sheba Medical Center identified hospitalized patients below the age of 40. The database was composed of the records of 750 patients (612 males, 138 females) who were hospitalized. The recurrence risk for SP after nonoperative treatment was significantly higher. Women were found to have an increased risk of SSP when having SP (OR 2.78). Asthma was the most prevalent disease causing SSP in young people. In this large cohort, we found that operative procedure has clear protective effect from recurrence in SP, so surgery should be positively considered when treating SP in hospitalized patients. Among young people and particularly in pediatric patients, when females have a SP, we strongly recommend looking for primary lung disease. More studies are needed to determine the risk factors and produce clear guidelines regarding surgery as first treatment.

Sections du résumé

BACKGROUND BACKGROUND
Pneumothorax can be classified as traumatic, iatrogenic or spontaneous (SP), which can be subdivided into primary spontaneous pneumothorax (PSP), a condition without preexisting lung disease, or secondary spontaneous pneumothorax (SSP) a complication of a preexisting lung disease. Recurrence rate of PSP is 30% whereas for SSP rate is unknown. This article explores the experience of a tertiary center over 20 years.
METHODS METHODS
A retrospective case review of patients hospitalized with pneumothorax to investigate the natural history and treatment of SP in a young population in a single tertiary center was conducted. A search of the digital archive (going back to 01/01/1995) of Sheba Medical Center identified hospitalized patients below the age of 40.
RESULTS RESULTS
The database was composed of the records of 750 patients (612 males, 138 females) who were hospitalized. The recurrence risk for SP after nonoperative treatment was significantly higher. Women were found to have an increased risk of SSP when having SP (OR 2.78). Asthma was the most prevalent disease causing SSP in young people.
CONCLUSIONS CONCLUSIONS
In this large cohort, we found that operative procedure has clear protective effect from recurrence in SP, so surgery should be positively considered when treating SP in hospitalized patients. Among young people and particularly in pediatric patients, when females have a SP, we strongly recommend looking for primary lung disease. More studies are needed to determine the risk factors and produce clear guidelines regarding surgery as first treatment.

Identifiants

pubmed: 33998780
doi: 10.1111/crj.13400
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

967-972

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Sahn SA, Heffner JE. Spontaneous pneumothorax. N Engl J Med. 2000;342:868-874.
Bintcliffe OJ, Hallifax RJ, Edey A, et al. Spontaneous pneumothorax: time to rethink management? Lancet Respir Med.  2015 Jul;3:578-588.
Melton LJ III, Hepper NGG, Offord KP. Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis. 1979;120:1379-1382.
MacDuff A, Arnold A, Harvey J, BTS Pleural Disease Guideline Group. Management of spontaneous pneumothorax: British Thoracic Society pleural disease guideline 2010. Thorax. 2010;65(Suppl 2):ii18-ii31.
Baumann MH, Strange C. Treatment of spontaneous pneumothorax. Chest. 1997;112:789-804.
Alifano M, Forti Parri SN, Bonfanti B, et al. Atmospheric pressure influences the risk of pneumothorax. Chest. 2007;131(6):1877-1882.
Noppen M, Verbanck S, Harvey J, et al. Music: a new cause of primary spontaneous pneumothorax. Thorax. 2004;59(8):722-724.
Chiu HT, Garcia CK. Familial spontaneous pneumothorax. Curr Opin Pulm Med. 2006 Jul;12(4):268-272.
Cardy CM, Maskell NA, Handford PA, et al. Familial spontaneous pneumothorax and FBN1 mutations. Am J Respir Crit Care Med. 2004 Jun;1:1260-1262.
Hsu HH, Chen JS. The etiology and therapy of primary spontaneous pneumothoraces. Expert Rev Respir Med. 2015 Oct;9(5):655-665.
Lichter I, Gwynne JF. Spontaneous pneumothorax in young subjects: a clinical and pathological study. Thorax. 1971 Jul;26(4):409-417.
Bintcliffe O, Maskell N. Spontaneous pneumothorax. BMJ. 2014 May 8;348:g2928.
Johannesma PC, Reinhard R, Kon Y, et al. Prevalence of Birt-Hogg-Dubé syndrome in patients with apparently primary spontaneous pneumothorax. Eur Respir J. 2015 Apr;45(4):1191-1194.
Tanaka F, Itoh M, Esaki H, Isobe J, Ueno Y, Inoue R. Secondary spontaneous pneumothorax. Ann Thorac Surg. 1993 Feb;55(2):372-376.
Huang Y, Huang H, Li Q, et al. Approach of the treatment for pneumothorax. J Thorac Dis. 2014 Oct;6:S416-S420.
Haynes D, Baumann MH. Management of pneumothorax. Semin Respir Crit Care Med. 2010 Dec;31(06):769-780.
Baumann MH, Strange C, Heffner JE, et al. Management of spontaneous pneumothorax: an American College of Chest Physicians Delphi consensus statement. Chest. 2001 Feb;119(2):590-602.
Tsuboshima K, Kurihara M, Yamanaka T, Watanabe K, Matoba Y, Seyama K. Does a gender have something to do with clinical pictures of primary spontaneous pneumothorax? [published online ahead of print, 2020 May 27]. Gen Thorac Cardiovasc Surg. 2020;68(8):741-745. https://doi.org/10.1007/s11748-020-01388-1
Sadikot RT, Greene T, Meadows K, Arnold AG. Recurrence of primary spontaneous pneumothorax. Thorax. 1997 Sep;52(9):805-809.
Brown SGA, Ball EL, Perrin K, et al. Conservative versus interventional treatment for spontaneous pneumothorax. N Engl J Med. 2020;382(5):405-415.
Brown RH, Wise RA, Kirk G, Drummond MB, Mitzner W. Lung density changes with growth and inflation. Chest. 2015 Oct;148(4):995-1002.
Cook CH, Melvin WS, Groner JI, Allen E, King DR. A cost-effective thoracoscopic treatment strategy for pediatric spontaneous pneumothorax. Surg Endosc. 1999 Dec;13(12):1208-1210.

Auteurs

Moshe Ashkenazi (M)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Alon Bak (A)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.

Ifat Sarouk (I)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Bat El Bar Aluma (BE)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Adi Dagan (A)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Yael Bezalel (Y)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Daphna Vilozni (D)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Ori Efrati (O)

Pediatric Pulmonology and National CF Center, Edmond and Lily Safra Children's Hospital, Sheba Medical Center, Tel-Hashomer, Israel.
Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv, Israel.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH